Ashby J, Styles J A, Paton D
Br J Cancer. 1978 Sep;38(3):418-27. doi: 10.1038/bjc.1978.223.
Experiments conducted in vitro are described which indicate that a family of specifically substituted phosphoramides may share the carcinogenic properties displayed by the structurally novel carcinogen, hexamethylphosphoramide (HMPA). Most of the analogues tested only gave a positive response in vitro when using a substantially modified liver homogenate activation system (S-9 mix). The analogy drawn in our earlier paper between this new class of potential carcinogens and the nitrosamine carcinogens, has been strengthened. The following compounds gave a positive response in the cell transformation assay of Styles: hexamethylphosphoramide (HMPA), hexamethylphosphorous triamide, hexamethylphosphorothioic triamide, tripiperidinophosphine oxide, phosphorothioic trimorpholide and diethoxymorpholinophosphine oxide (DEMPA).
本文描述了体外实验,这些实验表明,一类经过特定取代的磷酰胺可能具有结构新颖的致癌物六甲基磷酰胺(HMPA)所表现出的致癌特性。大多数测试的类似物仅在使用经过大幅改良的肝匀浆活化系统(S-9混合物)时,才在体外给出阳性反应。我们早期论文中得出的关于这类新的潜在致癌物与亚硝胺致癌物之间的类比,得到了进一步强化。以下化合物在斯泰尔斯的细胞转化试验中给出了阳性反应:六甲基磷酰胺(HMPA)、六甲基亚磷酰胺、六甲基硫代磷酰胺、三哌啶氧化膦、硫代磷酰三吗啉和二乙氧基吗啉基氧化膦(DEMPA)。